Porton Pharma Solutions Ltd. (SHE:300363)
China · Delayed Price · Currency is CNY 21.28
-0.60 (-2.74%)
Apr 29, 2026, 3:06 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 11.54 billion as of April 29, 2026. Its market cap has increased by 14.41% in one year.
Market Cap
11.54B
Enterprise Value
11.27B
Revenue
3.50B
Ranking
n/a
PE Ratio
93.98
Stock Price
21.28
Market Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 11.54B, an increase of 192.81%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 11.54B | -8.09% |
| Dec 31, 2025 | 12.55B | 45.94% |
| Dec 31, 2024 | 8.60B | -37.37% |
| Dec 29, 2023 | 13.73B | -38.42% |
| Dec 30, 2022 | 22.31B | -54.20% |
| Dec 31, 2021 | 48.70B | 145.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shyndec Pharmaceutical | 12.86B |
| Ningbo Menovo Pharmaceutical | 12.44B |
| Zhejiang Jiuzhou Pharmaceutical | 12.36B |
| Guangdong Taienkang Pharmaceutical | 12.34B |
| Zhejiang Jingxin Pharmaceutical | 12.31B |
| Henan Lingrui Pharmaceutical | 12.08B |
| Zhejiang Hisoar Pharmaceutical | 11.41B |
| Zhejiang CONBA Pharmaceutical | 11.24B |